Annual Report 2013 Amfar,The Foundation for AIDS Research

Annual Report 2013 amfAR,The Foundation for AIDS Research

Contents

amfAR in 2013: Program Highlights 01

Grants, Fellowships, and Awards 04

Research Grants

TREAT Asia Awards

GMT Initiative Awards

Public Policy Awards

Financial Highlights 10

Leadership and Advisory Committees 12

Board of Trustees

Scientific Advisory Committee

Program Advisory Council

Management Group

amfAR, The Foundation for AIDS Research, is dedicated to ending the global AIDS epidemic through innovative research. amfAR in 2013: Program Highlights

University in Portland is examining the macrophage—an immune cell that is closely related to the T cell—for its potential role in maintaining hidden reservoirs for HIV infection.

• amfAR convened a pair of think tanks in Amsterdam with European scientists in 2013. The first focused on the role of the immune system and immune-based therapies in attempts to eradicate HIV. The other led to the formation of a group of participating physicians and scientists committed to establishing a standard protocol for performing stem cell transplants in HIV-infected individuals who need them for reasons other than curing HIV.

• Research studies make the greatest impact on the AIDS field and on the broader scientific community when they are published in scientific journals. In 2013, close to 50 scientific publications resulted from amfAR-funded research. Research • Much excitement surrounded the case of “the Mississippi TREAT Asia child,” first reported by Dr. Deborah Persaud of Johns Hopkins Children’s Center in March 2013. A two-year-old child in • TREAT Asia (Therapeutics Research, Education, and AIDS Mississippi, born HIV positive, appeared to have been cured after Training in Asia) is a network of clinics, hospitals, and research being treated with antiretroviral therapy (ART) immediately after institutions working with civil society to ensure the safe and birth and then being taken off treatment. But during a routine effective delivery of HIV/AIDS treatments throughout Asia clinical visit more than a year later, the child was found to have and the Pacific. Facilitated by amfAR, TREAT Asia seeks detectable levels of virus in the blood. The case will nonetheless to strengthen HIV/AIDS care, treatment, and management remain an important landmark in AIDS research since no skills among healthcare professionals through education and other child born with HIV is known to have spent as long off training programs developed by experts in the region. antiretroviral therapy without experiencing a resurgence of virus. • In 2013, the TREAT Asia network began a regional study • amfAR continued to advance cure research through the amfAR of hepatitis C co-infection among people living with HIV. Research Consortium on HIV Eradication (ARCHE). In 2013, The study aims to develop a pilot model of care for treating the Foundation awarded nearly $3 million to 12 collaborative hepatitis C in resource-limited settings that can be replicated research teams in the United States, United Kingdom, France, throughout the region, where treatment for the disease is Thailand, and Australia working in the areas considered central costly and often inaccessible. to HIV eradication: expanding our understanding of latent viral • TREAT Asia provided social support awards to four reservoirs, developing a therapeutic vaccine, and examining organizations in its pediatric network in 2013 to bolster their pharmacological and gene therapy approaches to curing HIV. efforts to improve psychosocial support for HIV-positive young • amfAR awarded nearly $4 million in additional grants and people, keep them in school, and ensure they receive age- fellowships to support 20 research projects. Many of these appropriate medical treatment. awards were for cure-focused studies aimed at answering critical questions such as how, where, and why does HIV persist in infected people taking ART. Four researchers received Mathilde Krim Fellowships in Basic Biomedical Research, which provide funding for exceptional young researchers who are new to the field of HIV/AIDS research.

• ARCHE grantees continued to build on previous progress made with amfAR funding. Dr. Eric Arts of Case Western Reserve University in Cleveland, Ohio, is aiming to develop and test an HIV treatment that is specific to each patient’s virus and targets the latent viral reservoir. A team led by Dr. Nicolas Chomont of the Vaccine and Gene Therapy Institute in Port St. Lucie, Florida, is investigating the roles CD4+ T memory cells—the cells where HIV reservoirs mainly reside—may play as a potential target for a cure. Dr. Jonah Sacha of the Oregon Health and Science

2 1 • With support from ViiV Healthcare, TREAT Asia is conducting programs undermine the domestic and global response an ongoing study using an audio-computer-assisted survey to HIV; and strategies for tackling HIV among most-at- instrument (ACASI) to better understand how adolescents risk populations, which are often highly marginalized and experience living with HIV by allowing them to anonymously difficult to access. respond to questions using a computer interface. Survey topics • In July 2013, amfAR held three Congressional briefings include whether or not they are taking their medicines; if they in Washington, D.C. Two of the briefings, which were have tried alcohol, tobacco, or drugs; their sexual behavior; and co-sponsored with the Infectious Diseases Society of stigma they may have experienced at school or at home. America’s Center for Global Health Policy and the Elizabeth • TREAT Asia organized five workshops and training sessions in Glaser Pediatric AIDS Foundation, brought together 2013, including sessions on managing HIV and hepatitis C co- leading researchers to discuss the cutting-edge science infection; good clinical practice and research ethics; and clinical and evidence-based interventions needed to achieve an management of pediatric HIV. In addition, TREAT Asia developed AIDS-free generation. The third discussed the need to end a series of educational materials about hepatitis C infection and the ban on federal funding for SSPs to respond to rapidly treatment titled Life Loves the Liver that includes animated video increasing opiate use in the United States. The speakers segments, booklets, and flip charts on hepatitis C infection and included Seattle Police Chief Jim Pugel, Dr. Jennifer treatment. All materials have been produced in Bahasa Indonesia, Havens of the University of Kentucky, and Kristin Dubay- Chinese, English, Malay, Thai, and Vietnamese. Horton of the Bridgeport (CT) Health Department.

• amfAR developed An Action Agenda to End AIDS, a follow up to its 2012 Action Agenda released with AVAC at the International AIDS Conference. The report describes progress being made in certain areas, including increases in the total number of people on ART and the number of HIV-positive pregnant women receiving ART. The report also identifies areas where the global AIDS response is falling short, including the failure to scale up core HIV interventions in many areas and the failure to reduce widespread stigma and discrimination.

GMT Initiative • Since 2007, amfAR has been serving the HIV-related needs An image from The Exchange, amfAR’s short documentary advocating for of gay men, other men who has sex with men (MSM), and ending the ban on federal funding of syringe exchanges transgender individuals (collectively, GMT) throughout the developing world through its GMT Initiative. Through small, targeted grants to grassroots groups, amfAR helps expand Public Policy access to HIV education and prevention services; supports • Through its Public Policy office in Washington, D.C., amfAR educates policymakers, the media, and the public about evidence-based policies to address HIV/AIDS in the U.S. and around the world. In 2013, amfAR continued to promote rational AIDS-related policies based on the most current scientific knowledge.

• In 2013, amfAR produced four short films that illustrate the wide-ranging public health, public safety, and economic benefits of syringe services programs (SSPs) that combat the spread of HIV among people who inject drugs. The films support advocacy efforts aimed at overturning the ban on federal funding of SSPs.

• The Public Policy office produced a number of issue briefs, fact sheets, and infographics addressing the most pressing AIDS- related issues of 2013. Topics included addressing HIV among people who inject drugs and the value of SSPs; how budget Members of GMT Initiative grantee partner ASPIDH advocate for cuts to national and international HIV treatment and research transgender rights in El Salvador. (Photo: ASPIDH)

32 advocacy aimed at increasing funding for prevention and treatment services; and works to end stigma, discrimination, and violence that threaten the lives of GMT and fuel the spread of HIV/AIDS.

• In 2013, amfAR awarded more than $710,000 to 39 groups in Africa, the Caribbean, Eastern Europe and Central Asia, and Latin America. The awards support the work of grassroots groups working to reduce the spread and impact of HIV among GMT in hard hit regions of the developing world.

• The GMT Initiative made three awards as part of its Advocacy in Action program, which supports GMT-led community- based organizations that wish to influence the policies of governments and external donors. Four awards were made amfAR Ambassador Milla Jovovich, amfAR Global Fundraising Chairman under its Evidence in Action program, which documents and Sharon Stone, and Jessica Chastain during the 2013 Cinema Against AIDS evaluates the impact of community-based programs to better gala (Photo: Kevin Tachman) understand how to scale up the best strategies for stopping the spread of HIV among GMT. Evidence in Action was developed • amfAR has long benefited from the voices and the visibility of with support from ViiV Healthcare’s Positive Action Program a wide range of prominent public figures. In 2013, celebrity and the Elton John AIDS Foundation. Awards for these two supporters included amfAR Global Fundraising Chairman programs in 2013 totaled approximately $150,000. Sharon Stone, amfAR ambassadors Cheyenne Jackson, Janet • In May 2013, amfAR published Achieving an AIDS-Free Jackson, Milla Jovovich, Liza Minnelli, and Michelle Yeoh, as well Generation for Gay Men and Other MSM in Southern Africa, as Leonardo DiCaprio, Heidi Klum, Alan Cumming, Aishwarya with the Johns Hopkins Bloomberg School of Public Health. Rai, Abhishek Bachchan, Jessica Chastain, Hilary Swank, Kylie This report details how underfinancing, discrimination, and Minogue, Rosario Dawson, Rosie Perez, Zachary Quinto, Adrien stigma undermine efforts to address HIV among GMT in the Brody, Dita Von Teese, and Chelsea Handler, among many others. region and makes recommendations about how policymakers • The Battle of amfAR, a documentary telling the story of how Swiss can better address the needs of GMT. Individual country scientist Dr. Mathilde Krim and Hollywood movie star Elizabeth profiles on Botswana, Malawi, Namibia, Swaziland, Zambia, Taylor joined forces to create amfAR in 1985, was screened at and Zimbabwe were also produced to supplement the report. prominent film festivals throughout 2013 and was an Official • The GMT Initiative Blog, Grassroots, posted articles throughout Selection at the Sundance and Tribeca Film Festivals. It was the year that discuss how various HIV-related issues impact the produced by amfAR Chairman Kenneth Cole and premiered on GMT Initiative grantee partners’ lives and work. HBO in December 2013.

• amfAR’s Public information team produces a range of educational Public Information materials, program reports, and periodicals in an effort to communicate the Foundation’s message and the need for AIDS • amfAR continued to work closely with the media to raise the research. Its 2013 publications included: Innovations, amfAR’s profile of HIV/AIDS, both domestically and internationally, and newsletter; the TREAT Asia Report, which is distributed widely to to help ensure the accuracy of AIDS-related press coverage. an international audience; and a monthly e-mail newsletter sent to Articles and reports involving amfAR—many of which included more than 100,000 subscribers. interviews with amfAR spokespeople—were carried in • The amfAR website features news, interviews, editorials, and numerous media outlets, including The New York Times, The blog posts covering research, policy, and amfAR’s programs and Wall Street Journal, The Washington Post, the Associated activities. The Foundation also spreads its message on social Press, Reuters, Bloomberg News, CNN, and The Huffington media and has over 45,000 likes on Facebook, 20,000 Twitter Post. followers, and 6,000 Instagram followers.

43 2013 RESEARCH Optimizing Treatment 2013 TREAT ASIA GRANTS FELLOWSHIPS, GRANTS, Dissecting the mechanism of HIV-1 entry inhibition AND AWARDS AND AWARDS by novel small molecules Principal Investigator: Alon Herschhorn, Ph.D. Dana-Farber Cancer Institute All projects listed below were awarded Boston, MA *Supported by National Institutes of Health amfAR funding during the period October 1, $125,000 under National Institutes of Health cooperative 2012, through September 30, 2013. agreement number U01AI069907 with funds from the National Institute of Allergy and Infectious RESEARCH GRANTS Diseases, the National Cancer Institute, and the AMFAR RESEARCH CONSORTIUM ON HIV ERADICATION (ARCHE) Pursuing HIV Eradication Eunice Kennedy Shriver National Institute of Child Health and Development. Activation of latent HIV using an autologous HIV Immune correlates of viral rebound after vector therapeutic HIV vaccination Principal Investigator: Eric Arts, Ph.D. Principal Investigator: Christian Brander, Ph.D. **Supported by National Institutes of Health grant Case Western Reserve University Fundación IRSICAIXA number 5R01HD073972 with funds from the Cleveland, OH Barcelona, Spain Eunice Kennedy Shriver National Institute of Child $180,000 $349,964 Health and Development. Identifying and targeting HIV persistence in T cell Sorted bead sequencing to accurately assess HIV subsets during ART in reservoirs ADULT RESEARCH Principal Investigator: Nicolas Chomont, Ph.D. Principal Investigator: James Mullins, Ph.D. University of Washington Vaccine and Gene Therapy Institute of Florida TREAT ASIA HIV OBSERVATIONAL DATABASE Seattle, WA Port St. Lucie, FL (TAHOD) $590,285 $180,000 Romanee Chaiwarith, M.D., M.H.S. Programming stem cells with a chimeric antigen HIV-1 cellular immunity during serial and repetitive panobinostat dosing Chiang Mai University - Research Institute for receptor to eradicate HIV Health Sciences Principal Investigator: Scott Kitchen, Ph.D. Principal Investigator: Lars Ostergaard, M.D., Ph.D., DMSc Chiang Mai, Thailand University of California, Los Angeles $20,000* Los Angeles, CA Aarhus University Aarhus, Denmark $300,000 Jun Yong Choi, M.D., Ph.D. $180,000 Yonsei University College of Medicine HIV antigen within the latent reservoir: a new Effects of CCR5-Δ32 heterozygosity on the HIV-1 Seoul, South Korea assay for eradication trials $16,500* Principal Investigator: David Margolis, M.D. reservoir Principal Investigator: Satish Pillai, Ph.D. The University of North Carolina at Chapel Hill Rossana Ditangco, M.D. Regents of the University of California, San Chapel Hill, NC Asian Foundation for Tropical Medicine, Inc. Francisco $166,748 Muntinlupa City, Philippines $178,753 $20,000* Evaluating the threat posed by intact, non- Blood Systems, Inc. induced proviruses $168,773 (transfer) Adeeba Kamarulzaman, M.B.B.S., F.R.A.C.P. Principal Investigator: Robert F. Siliciano, M.D., University of Malaya Plasmacytoid dendritic cells in immune activation Ph.D. Kuala Lumpur, Malaysia and HIV/SIV persistence Johns Hopkins University $20,000* Baltimore, MD Principal Investigator: Roger Keith Reeves, Ph.D. $180,000 New England Primate Research Center, President Pacharee Kantipong, M.D. and Fellows of Harvard College Chiangrai Prachanukroh Hospital Southborough, MA Chiang Rai, Thailand $178,800 $6,750* (year 7)/$13,500* (year 8) MATHILDE KRIM FELLOWS IN BASIC BIOMEDICAL RESEARCH The role of macrophages as a latent reservoir of Sasisopin Kiertiburanakul, M.D., M.H.S. HIV Ramathibodi Hospital, Mahidol University Preventing HIV Transmission Principal Investigator: Jonah Sacha, Ph.D. Bangkok, Thailand Oregon Health and Science University $20,000* Cross-species transmission events that led to the Portland, OR HIV-1 pandemic $180,000 Nagalingeswaran Kumarasamy, M.D., M.B.B.S, Principal Investigator: Lucie Etienne, Ph.D. Ph.D. Fred Hutchinson Cancer Research Center Impact of ZFN CCR5-modified autologous CD4 YRG Centre for AIDS Research and Education, Seattle, WA T-cells on HIV persistence VHS $125,000 Principal Investigator: Rafick-Pierre Sékaly, Ph.D. Chennai, India Vaccine and Gene Therapy Institute of Florida $20,000* Structural studies of glycan-specific sites of Port St. Lucie, FL Christopher Lee, M.B.B.S., M.R.C.P. vulnerability on HIV-1 gp120 $179,984 Sungai Buloh Hospital Principal Investigator: Leopold Kong, D.Phil. Sungai Buloh, Malaysia Impact of CMV replication on HIV latent reservoir The Scripps Research Institute $15,000* La Jolla, CA Principal Investigator: Sara Gianella Weibel, M.D. $125,000 Veterans Medical Research Foundation Patrick Li, M.B.B.S. San Diego, CA Queen Elizabeth Hospital Pursuing HIV Eradication $180,000 Hong Kong, China $20,000* Impact of cancer and transplant therapy on HIV-1 reservoirs Tuti Parwati Merati, M.D., Ph.D. Principal Investigator: Christine Durand, M.D. RESEARCH WORKSHOPS AND MEETINGS Udayana University School of Medicine Johns Hopkins University The International Workshop on HIV Dynamics and Denpasar, Indonesia Baltimore, MD Evolution $18,500* $125,000 Principal Investigator: Steven Wolinsky, M.D. $80,000 (Phase II) Shinichi Oka, M.D., Ph.D. Northwestern University National Center for Global Health and Medicine Chicago, IL Shinjuku, Japan $5,850 $16,000* 54 Oon Tek Ng, M.B.B.S., M.R.C.P., M.P.H. Tuti Parwati Merati, M.D., Ph.D. Robert Finlayson, M.B.B.S., Dip. Ven. Tan Tock Seng Hospital Udayana University School of Medicine Taylor Square Private Clinic Singapore, Singapore Denpasar, Indonesia Darlinghurst, Australia $16,000* $4,600* $5,775*† Praphan Phanuphak, M.D., Ph.D. Oon Tek Ng, M.B.B.S., M.R.C Jennifer Hoy, M.B.B.S. HIV-NAT/Thai Red Cross AIDS Research Center Tan Tock Seng Hospital Victorian HIV Service, Infectious Diseases Bangkok, Thailand Singapore, Singapore Department $20,000* $1,050* The Alfred Hospital Melbourne, Australia Sanjay Pujari, M.D., AAHIVS Praphan Phanuphak, M.D., Ph.D. $6,075* Institute of Infectious Diseases HIV-NAT/Thai Red Cross AIDS Research Center Pune, India Bangkok, Thailand Eva Jackson, M.B.B.S. $20,000* $500* Blue Mountains Sexual Health and HIV Clinic Katoomba, Australia Winai Ratanasuwan, M.D. Phạm Thị Thanh Thuẏ M.D., Ph.D. $1,050 Siriraj Hospital, Mahidol University Bach Mai Hospital Bangkok, Thailand Hanoi, Vietnam Mark Kelly, M.B.B.S. $7,500* (year 7)/$7,350* (year 8) $3,550* Prince Charles Hospital Brisbane Sexual Health and HIV Service Pham Thi Thanh Thuy, M.D., Ph.D. Nguyen Van Kinh, M.D., Ph.D. Brisbane, Australia Bach Mai Hospital National Hospital of Tropical Diseases $4,950* Hanoi, Vietnam Hanoi, Vietnam $20,000* $3,700* Richard Moore Northside Clinic (Vic), Pty., Ltd. Nguyen Van Kinh, M.D., Ph.D. Wing-Wai Wong, M.D. North Fitzroy, Australia National Hospital of Tropical Diseases Taipei Veterans General Hospital $7,500*† Hanoi, Vietnam Taipei City, Taiwan, Republic of China $20,000* $900* (year 1)/$1,500* (year 2) David Nolan Royal Perth Hospital Saphonn Vonthanak, M.D., Ph.D. Evy Yunihastuti, M.D., Ph.D. Perth, Australia National Center for HIV/AIDS, Dermatology & Cipto Mangunkusumo General Hospital $4,950* STDs Jakarta, Indonesia Cambodia National Institute of Public Health $1,850* David Orth, M.B., B.S., Dip. Ven. Phnom Penh, Cambodia Gladstone Road Medical Centre $20,000* Fujie Zhang, M.D. Highgate Hill, Australia Beijing Ditan Hospital, Capital Medical University $4,800*† Wing-Wai Wong, M.D., Sc.D Beijing, China Taipei Veterans General Hospital $3,000* Tim Read Taipei City, Taiwan, Republic of China Melbourne Sexual Health Centre $20,000* Carlton, Australia $5,175* Evy Yunihastuti, M.D., Ph.D. AUSTRALIA HIV OBSERVATIONAL DATABASE Cipto Mangunkusumo General Hospital (AHOD) Norman Roth, M.B.B.S., F.A.Ch.S.H.M. Jakarta, Indonesia Prahran Market Clinic, Pty., Ltd. $20,000* Debbie Allen, M.B.Ch.B., Dip. South Yarra, Australia Central Coast Local Health District $6,000* Fujie Zhang, M.D., M.P.H. Holden Street Clinic Beijing Ditan Hospital, Capital Medical University Gosford, Australia Darren Russell, M.D. Beijing, China $1,500 Cairns Sexual Health Service $16,000* Cairns, Australia David Baker, B.H.B. $5,175* East Sydney Doctors Darlinghurst, Australia Nathan Ryder, M.D. TAHOD STUDY ON THE SOCIO-ECONOMIC $7,500*† Northern Territory Dept of Health & Community DETERMINANTS OF TUBERCULOSIS IN ASIA Services Mark Bloch, M.D. Sexual Health & Blood Borne Virus Program Rossana Ditangco, M.D. Holdsworth House Medical Practice Darwin, Australia Asian Foundation for Tropical Medicine, Inc. Darlinghurst, Australia $900 (as intermediary for the Research Institute of $6,300*† Tropical Medicine) David Smith Muntinlupa City, Philippines Katherine Brown, M.D. Sexual Health and AIDS Services $900* Illawarra Shoalhaven Local Health District Lismore, Australia Wollongong, Australia $6,600* Adeeba Kamarulzaman, M.B.B.S., F.R.A.C.P. $1,425 University of Malaya David Sowden, M.B.B.S Kuala Lumpur, Malaysia David Cooper, M.D. Sunshine Coast Hospital and Health Service $1,300* St. Vincent’s Hospital Sydney Limited Nambour, Australia Darlinghurst, Australia $7,500* Sasisopin Kiertiburanakul, M.D., M.H.S. $6,825* Ramathibodi Hospital, Mahidol University Sharon Taylor, C.N.C. Bangkok, Thailand William Donohue, M.B.B.S. Hunter New England Health $500* O’Brien Street Practice Tamworth Sexual Health Service Adelaide, Australia Tamworth, Australia Christopher Lee, M.B.B.S., M.R.C.P $1,575 $900 Sungai Buloh Hospital Sungai Buloh, Malaysia David Ellis, M.B.B.S. David Templeton, Ph.D. $6,870* (year 1)/$600* (year 2) D.A. Ellis, Pty., Ltd. RPA Sexual Health Clinic Coffs Harbour, Australia Camperdown, Australia Patrick Li, M.B.B.S. $750† $750 Queen Elizabeth Hospital Hong Kong, China $300*

65 Rick Varma, M.R.C.P. Clinical epidemiology of tuberculosis infection Nia Kurniati, M.D. Nepean Sexual Health Clinic among PLWHA in Taiwan Cipto Mangunkusumo General Hospital Kingswood, Australia Yi-Ming Chen, M.D., Sc.D. Jakarta, Indonesia $900 Kaohsiung Medical University $10,650 Kaohsiung, Taiwan, Republic of China Ian Woolley, M.B.B.S., F.R.A.C.P. $19,042* Pagakrong Lumbiganon, M.D. Monash Health, Monash Medical Centre - Clayton Srinagarind Hospital, Khon Kaen University Melbourne, Australia Clinical epidemiology of tuberculosis infection Khon Kaen, Thailand $4,125* among PLWHA in Taiwan $15,890 Yi-Ming Chen, M.D., Sc.D. Lynne Wray, M.B.B.S. National Yang-Ming University Fong Siew Moy, M.D. Sydney Sexual Health Centre, Sydney Hospital Taipei, Taiwan, Republic of China Hospital Likas Sydney, Australia $26,800* Kota Kinabalu, Malaysia $4,575* $5,000 (supplemental funding year 6)/ Asia Pacific HIV research collaboration: $7,545 (year 7) † funding to private medical practices provided by AHOD, HCV outcomes program technical support agreements Matthew G. Law, Ph.D. Revathy Nallusamy, M.B.B.S. University of New South Wales Penang Hospital Sydney, Australia Georgetown, Malaysia HCV STUDY PREPARATION AWARD $241,548* $2,695 Adeeba Kamarulzaman, M.B.B.S., F.R.A.C.P. Asia Pacific HIV research collaboration: Kamarul Razali, M.D. University of Malaya cancer studies Pediatric Institute, Hospital Kuala Lumpur Kuala Lumpur, Malaysia Matthew G. Law, Ph.D. Kuala Lumpur, Malaysia $3,500 University of New South Wales $9,150 Sydney, Australia Virat Sirisanthana, M.D. Kiat Ruxrungtham, M.D. $44,271* HIV-NAT/Thai Red Cross AIDS Research Center Chiang Mai University Bangkok, Thailand Asia Pacific HIV research collaboration: TAHOD Research Institute for Health Sciences $3,500 Matthew G. Law, Ph.D. Chiang Mai, Thailand University of New South Wales $16,760* Nguyen Van Kinh, M.D., Ph.D. Sydney, Australia Ketut Dewi Kumara Wati, M.D. National Hospital of Tropical Diseases $221,907* Hanoi, Vietnam Udayana University School of Medicine $3,500 Identifying biomarkers of anal intraepithelial Denpasar, Indonesia neoplasia in Thai MSM $5,000 (supplemental funding year 6)/$8,105 Evy Yunihastuti, M.D., Ph.D. Nittaya Phanuphak, M.D., Ph.D. Cipto Mangunkusumo General Hospital Nguyen Van Lam, M.D. HIV-NAT/Thai Red Cross AIDS Research Center National Hospital of Pediatrics Jakarta, Indonesia Bangkok, Thailand $3,500 Hanoi, Vietnam $15,000*/$95,000* $21,500 Study on anal human papillomavirus infection Do Chau Viet, M.D. EFFECTIVENESS AND TOLERABILITY OF HCV and anal intraepithelial neoplasia among men Children’s Hospital 2 TREATMENT IN HIV CO-INFECTED PATIENTS: who have sex with men in Indonesia, Malaysia, Ho Chi Minh City, Vietnam SCREENING and Thailand $15,860 Nittaya Phanuphak, M.D., Ph.D. Adeeba Kamarulzaman, M.B.B.S., F.R.A.C.P. HIV-NAT/Thai Red Cross AIDS Research Center Saphonn Vonthanak, M.D. University of Malaya Bangkok, Thailand National Center for HIV/AIDS, Dermatology & Kuala Lumpur, Malaysia $36,098* STDs $25,200* Cambodia National Institute of Public Health Phnom Penh, Cambodia Kiat Ruxrungtham, M.D. $33,445 HIV-NAT/Thai Red Cross AIDS Research Center PEDIATRIC RESEARCH Bangkok, Thailand TREAT ASIA PEDIATRIC HIV OBSERVATIONAL Nik Khairulddin Nik Yusoff, M.D. $25,200* DATABASE (TAPHOD) Hospital Raja Perempuan Zainab II Kota Bharu, Malaysia Nguyen Van Kinh, M.D., Ph.D. Torsak Bunupuradah, M.D. $1,920 (supplemental funding year 6)/ National Hospital of Tropical Diseases HIV-NAT/Thai Red Cross AIDS Research Center $8,055 (year 7) Hanoi, Vietnam Bangkok, Thailand $25,200* $15,740* Evy Yunihastuti, M.D., Ph.D. Kulkanya Chokephaibulkit, M.D. TREAT ASIA STUDIES TO EVALUATE Cipto Mangunkusumo General Hospital Siriraj Hospital, Mahidol University RESISTANCE – PEDIATRICS (TASER-P) Jakarta, Indonesia Bangkok, Thailand $29,700* Kulkanya Chokephaibulkit, M.D. $17,165 Siriraj Hospital, Mahidol University Rawiwan Hansudewechakul, M.D. Bangkok, Thailand $13,500 (Individual projects) Chiangrai Prachanukroh Hospital Chiang Rai, Thailand Trương Hữu Khanh, M.D. Clinical epidemiology of cancer among $24,050 Children’s Hospital 1 PLHA in Taiwan Trương Hữu Khanh, M.D. Ho Chi Minh City, Vietnam Yi-Ming Chen, M.D., Sc.D. $22,500 Kaohsiung Medical University Children’s Hospital 1 Kaohsiung, Taiwan, Republic of China Ho Chi Minh City, Vietnam Pope Kosalaraksa, M.D. $15,167* (year 2)/$30,000* (year 3) $26,850 Srinagarind Hospital, Khon Kaen University Nagalingeswaran Kumarasamy, M.D., M.B.B.S. Khon Kaen, Thailand Clinical epidemiology of cancer among $2,090 (supplement year 3)/$13,500 (year 4) PLHA in Taiwan YRG Centre for AIDS Research and Education, Yi-Ming Chen, M.D., Sc.D. VHS National Yang-Ming University Chennai, India Taipei, Taiwan, Republic of China $9,715 $20,300*

76 Nia Kurniati, M.D. Nik Khairulddin Nik Yusoff, M.D. Promote early disclosure of HIV status in Thai Cipto Mangunkusumo General Hospital Hospital Raja Perempuan Zainab II children with perinatal HIV infection Jakarta, Indonesia Kelantan, Malaysia Jintanat Ananworanich, M.D., Ph.D. $460 (supplement year 3 /$13,500 (year 4) $2,000* (year 1)/$2,100* (year 2) HIV-NAT/Thai Red Cross AIDS Research Centre Bangkok, Thailand Wasana Prasitsuebsai, M.D. $15,000 HIV-NAT/Thai Red Cross AIDS Research Center Bangkok, Thailand HUMAN PAPILLOMAVIRUS (HPV) INFECTION IN HIV and HBV co-infection among perinatally $18,500 PERINATALLY HIV-INFECTED ADOLOESCENTS HIV-infected adolescents in Asia: whole IN ASIA genome sequencing Virat Sirisanthana, M.D. Jintanat Ananworanich, M.D., Ph.D. Linda Aurpibul, M.D. Chiang Mai University Chiang Mai University Research Institute for Health Sciences HIV-NAT/Thai Red Cross AIDS Research Center (as study site) Chiang Mai, Thailand Chiang Mai, Thailand $3,000* $110 (supplement year 3)/$9,500 (year 4) Bangkok, Thailand $17,250** (year 1)/$32,175** (year 2) Bone mineral density among HIV-Infected Nguyen Van Lam, M.D., M.S.C. adolescents National Hospital of Pediatrics Kulkanya Chokephaibulkit, M.D. Siriraj Hospital Mahidol University Kulkanya Chokephaibulkit, M.D. Hanoi, Vietnam Siriraj Hospital, Mahidol University $18,500 Bangkok, Thailand $24,900** (year 1)/$59,076** (year 2) Bangkok, Thailand Do Chau Viet, M.D. $3,253* Children’s Hospital 2 Rawiwan Hansudewechakul, M.D. Chiangrai Prachanukroh Hospital Cardiovascular abnormalities and carotid intima- Ho Chi Minh City, Vietnam media thickness among HIV-infected adolescents $20,500 Chiang Rai, Thailand $49,505** in Thailand (supplemental funding) Kulkanya Chokephaibulkit, M.D. Thoa Kim Le Phan, M.D. Siriraj Hospital, Mahidol University UNDERSTANDING ADHERENCE, STIGMA, Children’s Hospital 1 Bangkok, Thailand AND BEHAVIORAL RISK FACTORS OF Ho Chi Minh City, Vietnam $5,000 ADOLESCENTS IN TApHOD USING AUDIO $20,885** COMPUTER ASSISTED SELF-INTERVIEW Social support award for children and (ACASI) Nittaya Phanuphak, M.D., Ph.D adolescents with HIV HIV-NAT/Thai Red Cross AIDS Research Center Rawiwan Hansudewechakul, M.D. Jintanat Ananworanich, M.D., Ph.D. (as data magagement center) Chiangrai Prachanukroh Hospital HIV-NAT/Thai Red Cross AIDS Research Center Bangkok, Thailand Chiang Rai, Thailand (as study site) $125,362** (year 1)/$220,255** (year 2) $14,702 Bangkok, Thailand $4,645* (year 1)/$5,475* (year 2) Nguyen Van Truong, M.D. Comparing interventions to improve Hung Vuong Hospital cARTadherence of HIV+ adolescents Kulkanya Chokephaibulkit, M.D. Ho Chi Minh City, Vietnam and young adults Siriraj Hospital Mahidol University $50,095** Stephen Kerr, Ph.D. Bangkok, Thailand HIV-NAT/Thai Red Cross AIDS Research Center $4,675* (year 1)/$5,292* (year 2) Bangkok, Thailand $105,491 Rawiwan Hansudewechakul, M.D. TRANSITIONING FROM PEDIATRIC TO ADULT Chiangrai Prachanukroh Hospital HIV CARE IN THAILAND AND VIETNAM Asia Pacific HIV Research Collaboration: TApHOD Chiang Rai, Thailand Kulkanya Chokephaibulkit, M.D. Matthew G. Law, Ph.D. $4,810* (year 1)/$5,050* (year 2) Siriraj Hospital, Mahidol University University of New South Wales Bangkok, Thailand Sydney, Australia Trương Hữu Khanh, M.D. $237,874* Children’s Hospital 1 $729 Ho Chi Minh City, Vietnam Rawiwan Hansudewechakul, M.D. Social support award 2013–2014 $4,400* Chiangrai Prachanukroh Hospital Fong Siew Moy, M.D. Hospital Likas Pagakrong Lumbiganon, M.D. Chiang Rai, Thailand $1,010 Kota Kinabalu, Malaysia Srinagarind Hospital, Khon Kaen University $5,650 Khon Kaen, Thailand Trương Hữu Khanh, M.D. $4,475* (year 1)/$3,635* (year 2) Children’s Hospital 1 Social support for children and adolescents with HIV for Penang Site, Malaysia Fong Siew Moy, M.D. Ho Chi Minh City, Vietnam $700 Revathy Nallusamy, M.B.B.S. Hospital Likas Penang Hospital Kota Kinabalu, Malaysia Georgetown, Malaysia $1,300* (year 1)/$1,500* (year 2) $4,481 (Individual projects) Wasana Prasitsuebsai, M.D., M.P.H. Support caregivers and social workers to improve HIV-NAT/Thai Red Cross AIDS Research Center CHAMP+ Asia Study disclosure process to HIV+ children (as data management center) Jintanat Ananworanich, M.D., Ph.D. Le Ngoc Oanh, M.D. Bangkok, Thailand HIV-NAT/Thai Red Cross AIDS Research Center Worldwide Orphans Foundation $8,000* Bangkok, Thailand Maplewood, NJ $40,000* (year 1)/$35,000* (year 2) Kamarul Razali, M.D. $14,927 Pediatric Institute, Hospital Kuala Lumpur Effect of socioeconomic factors on cognition, Prevalence of HLA-B*5701 among HIV-infected Kuala Lumpur, Malaysia adaptive function and school status children in Thailand and Cambodia: implications $2,100* (year 1)/$1,700* (year 2) Jintanat Ananworanich, M.D., Ph.D. for abacavir use HIV-NAT/Thai Red Cross AIDS Research Center Nguyen Van Lam, M.D., M.S.C. Thanyawee Puthanakit, M.D. Bangkok, Thailand HIV-NAT / Thai Red Cross AIDS Research Center National Hospital of Pediatrics $57,276 Hanoi, Vietnam Bangkok, Thailand $4,200* (year 1)/$2,800* (year 2) $15,964

87 Our Village Transgender HIV and sexual health research Latin America John Tucker and awareness project New Hope for Cambodian Children Transgender and Intersex Africa If you saw your mother (Si te viera tu madre) Killeen, Texas Pretoria, South Africa Red de personas viviendo con VIH/SIDA Mar del $39,029 $20,000 Plata/ATTTA Costa atlantica Mar Del Plata, Argentina Hepatitis B testing Strengthening healthcare access for $19,900 John Tucker GMT in Swaziland New Hope for Cambodian Children Rock of Hope Gender identity law for Bolivia: my identity Killeen, TX Manzini, Swaziland my right $3,630 $22,000 Red Nacional De Mujeres Trans (RED TREBOL) Cochabamba, Bolivia Training for early disclosure for children and Capacity strengthening and advocacy for MSM $20,000 adolescents in National Pediatric Hospital organizations in Togo Vibol Ung, M.D. MEN’S Advocacy during the electoral process for National Pediatric Hospital L o m é , To g o resource mobilization in order to respond to Phnom Penh, Cambodia $20,000 HIV/AIDS in GMT and fight homophobia $9,820 CES/MUMS Movimiento Por la Diversidad Sexual GMT health is a human right Santiago, Chile Spectrum Uganda Initiatives, Inc. $20,000 Kampala, Uganda 2013 GMT INITIATIVE AWARDS $20,000 Working for a dignified life free of stigma and discrimination for women Colectivo Unidad Color Rosa San Pedro Sula, Honduras Africa Caribbean $19,859 Improving social and health conditions for LBGTI Working together to enhance the MSM community Closing the gaps, integrating communities sex workers in Bukavu/South Kivu Province in the in Antigua and Barbuda II (phase II) Democratic Republic of Congo Antigua Resilience Collective, Inc. (ARC) Asociación Jóvenes en Movimiento (AJEM) Humanitarian Action for Health and Community S t . J o h n ’s , A n t i g u a a n d B a r b u d a Tegucigalpa, Honduras Development (AHUSADEC) $14,700 $20,000 B u k a v u , DRC Dominica healthy men (DO-HEM) project $19,984 Strengthening community health services for Dominica Planned Parenthood Association transgender people Reducing HIV vulnerability and the disease burden R o s e a u , D o m i n i c a Centro de Desarrollo e Investigación sobre through economic viability among the GMT $19,250 Juventud, A.C. population within Kisumu County Píldoras para la vida (Pills for life) Campeche, Mexico Men Against AIDS Youth Group (MAAYGO) Comunidad de Trans Travesti Trabajadoras $20,000 Kisumu, Kenya Sexuales Dominicanas (COTRAVETD) $20,000 Indigenous youth MSM and inclusive schools S a n C a r l o s , D o m i n i c a n R e p u b l i c against HIV Enhancing ARV adherence for gay men, MSM, $17,500 Interculturalidad, Salud y Derechos A.C. (INSADE) and transgender (GMT) individuals and male sex Education and testing to reduce HIV and HPV Mexico City, Mexico workers (MSW) in Kenya disease in Dominican MSM/transgender $14,440 Health Options for Young Men on HIV, AIDS and Instituto Dominicano de Estudios Virologicos STIs (HOYMAS) Promoting access to culturally appropriate (IDEV) N a i r o b i , K e n y a HIV services and healthcare for gay men and S a n t o D o m i n g o , D o m i n i c a n R e p u b l i c $20,000 transgender women in Iquitos through public $17,500 policy change GMT sexual health advocacy and rights project Strengthening the community response, access Gay Youth in Action against AIDS (GYAA ) (G-SHARP) to care and treatment Iquitos, Peru Stop AIDS in Liberia (SAIL) The Network of Guyanese Living with and Affected $ 20,000 M o n r o v i a , L i b e r i a by HIV/AIDS (G+) $20,000 Georgetown, Guyana Al Borj Center for Reproductive and Sexual Health $17,494 Eastern Europe and Central Asia Name Witheld by Request Owning our courage: enhancing GMT organizing Mainstreaming HIV/AIDS prevention activities for Marrakesh, Morocco efforts in Haiti GMT in Armenia through holistic approaches $20,000 KOURAJ Pou Pwoteje Dwa Moun We for Civil Equality (WFCE) Creating space for MSM to dialogue with P o r t a u P r i n c e , H a i t i Yerevan, Armenia policymakers on national and state plans for $17,500 $14,982 MSM HIV prevention and treatment Across the lines Introduction of the innovative VCT methodologies New HIV Vaccine and Microbicide Advocacy The Ashe Company for the MSM population Society (NHVMAS) Kingston, Jamaica Association Partnerships in Health (PIH) Lagos, Nigeria $17,496 Sarajevo, Bosnia-Herzegovina $19,789 $14,280 Get up, stand up Engaging MSM in advocating for the Jamaica AIDS Support for Life (JASL) Coming out implementation of national policies that ensure K i n g s t o n , J a m a i c a Public Association “Azimut Plus” access to comprehensive HIV prevention $17,500 Karaganda, Kazakhstan Health Development Initiative-Rwanda (HDI) $15,050 Kigali, Rwanda Fight the hate: mitigating risks and enabling safe $19,980 spaces for LGBT Jamaicans (phase II) Security for LGBT: fighting against violence and Jamaica Forum for Lesbians, All-Sexuals & Gays promoting human rights Accreditation of training manual to provide (J-FLAG) Kyrgyz Indigo competent services to GMT individuals Kingston, Jamaica Bishkek, Kyrgyzstan OUT Lesbian/Gay/Bisexual/Transgender (LGBT) $17,500 $19,952 Wellbeing P r e t o r i a , S o u t h A f r i c a $18,500

98 On a positive wave EVIDENCE IN ACTION AWARDS 2013 PUBLIC POLICY Public Association Pathfinder Bishkek, Kyrgyzstan Improving access to HIV and STI prevention and AWARDS $14,995 care services amongst GMT in Belize Collaborative Network of Persons Living with HIV GMT mobilization and integration to improve the (C-NET+) Harm reduction investment: analysis of the secondary health system Belize City, Belize Global Fund Association for Support of Marginalized Workers $26,594 Principal Investigator: Jamie Bridge STAR-STAR Skopje Phase 2: medical, psychological and HIV/AIDS International Drug Policy Consortium Skopje, Macedonia London, United Kingdom $12,000 prevention for MSM Asociación ALFIL $20,000 Improving GMT individuals’ access to HIV testing Quito, Ecuador Syringe exchange in the U.S., 2012–2013: in Montenegro $24,066 assessing services in a financially challenging Juventas Abriendo caminos 2.0 environment Podgorica, Montenegro Principal Investigator: Don C. Des Jarlais, Ph.D. $14,920 Asociación Solidaria Para Impulsar El Desarrollo Humano (ASPI-DH ARCO IRIS) Beth Israel Medical Center – Edmond de Multimodal approach to HIV and STI prevention San Salvador, El Salvador Rothschild Chemical Dependency Institute at primary and secondary levels among the GMT $20,000 New York, NY population in Belgrade $90,000 Safe Pulse of Youth (SPY) Operational research to determine effective strategies for mobilization of the GMT population Researching & advocating for civil society Belgrade, Serbia participation & influence in PEPFAR and Global $20,000 to access HIV prevention, treatment, and care ISHTAR MSM Fund budget allocation processes in Zimbabwe Reduction of HIV transmission and support for Nairobi, Kenya Principal Investigator: Nhlanhla Ndlovu GMT $26,000 Centre for Economic Governance and AIDS in Q-Club Africa Belgrade, Serbia Howick, South Africa $60,000 $15,000 GENERAL GMT INITIATIVE AWARDS Accessible, quality, and reliability, on equal terms Changing faces/changing spaces conference Equal Opportunities (EO) The East African Sexual Health & Rights Initiative 2013 COMMUNITY OUTREACH AWARDS Dushanbe, Tajikistan (UHAI EASHRI) $20,200 Nairobi, Kenya Gay Men’s Health Crisis, Inc. $10,000 Marjorie J. Hill, Ph.D. New York, NY ADVOCACY IN ACTION AWARDS Global lube access mobilization $5,000 AIDS Foundation of Chicago Mainstreaming LGBT issues into national Chicago, USA Dignitas International healthcare and service delivery $7,500 Marilyn McHarg Lesbians, Gays and Bisexuals of Botswana Toronto, Canada (LEGABIBO) The Lancet series, HIV in MSM Africa, launch $130,000 Johns Hopkins University Gaborone, Botswana Viva Cazuza $20,000 Baltimore, USA $48,500 Christina Moreira Advocacy for appropriate healthcare needs for Rio de Janeiro, Brazil MSM in the city of Yaoundé The Lancet series, HIV in MSM South America, $35,000 Humanity First Cameroon launch Yaoundé, Cameroon Johns Hopkins University $15,000 Baltimore, USA $15,107 Advocacy in action 2.0 China 2013 Chengdu Love & Kindness Group HIV research among MSM in developing world Chengdu Ai Ren Tong Meng settings Chengdu, China University Of Pittsburgh $17,000 Pittsburgh, USA $10,200 Advocacy for access to education for trans women Asociación Silueta X Guayaquil, Ecuador $15,000 Advocacy in action 2.0 Lao PDR 2013 Lao Positive Health Association (LaoPHA) Vientiane, Lao PDR $18,000 Advocacy in action 2.0 Thailand 2013 Health and Opportunity Network (HON) Bangkok, Thailand $18,135

109 Financial Highlights For the year ended September 30, 2013

Public Support and Revenue Public support $ 7,086,162 Special events 16,267,375 Planned giving 1,236,833 Government funding 4,641,817 Investment income and other revenue 710,734 Total public support and revenue $ 29,942,921

Expenses Research $ 8,157,695 TREAT Asia 6,013,057 GMT Initiative 2,472,397 Public Policy 2,046,107 Public Information 3,432,973 Total program services $ 22,122,229

Fundraising 5,118,865 Management and general 2,321,908 Total supporting services $ 7,440,773

Total expenses $ 29,563,002

Change in net assets 379,919 Net assets, beginning of year 30,752,104

Net assets, end of year $ 31,132,023

Statement of Financial Position

Assets Cash and investments $ 32,197,408 Pledges and receivables 13,641,950 Prepaid expenses and other assets 2,209,668 Furniture, equipment, and leasehold improvements 1,975,311 Total Assets $ 50,024,337

Liabilities Accounts payable and accrued expenses $ 1,688,090 Grants and fellowships payable, net 2,200,512 Deferred support and refundable advances 13,321,993 Other long-term liabilities 1,681,719 Total liabilities $ 18,892,314

Total net assets 31,132,023

Total liabilities and net assets $ 50,024,337

1110 Expenses

Fundraising $ 5,118,865 Management and general 2,321,908 Program 22,122,229

Total $ 29,942,921

Program Expenses

Research $ 8,157,695 TREAT Asia 6,013,057 GMT Initiative 2,472,397 Public Policy 2,046,107 Public Information 3,432,973

Total $ 22,122,229

11 12 T. Ryan Greenawalt TRUSTEES EMERITI BOARD OF TRUSTEES President/Founder Fiscal year 2013 Harrison Street Productions Arthur J. Ammann, M.D. New York, NY President, Global Strategies for HIV Prevention Clinical Professor of Pediatrics Chairman of the Board Regan Hofmann University of California, San Francisco Kenneth Cole Policy Officer Medical Center Chairman Washington Liaison Office San Rafael, CA Kenneth Cole Productions UNAIDS New York, NY Washington, D.C. Arnold W. Klein, M.D. Professor of Medicine/Dermatology Founding Chairman Michael J. Klingensmith University of California, Los Angeles Mathilde Krim, Ph.D. CEO and Publisher Beverly Hills, CA Adjunct Professor Minneapolis Star Tribune Mailman School of Public Health Minneapolis, MN Columbia University New York, NY Kevin McClatchy IN MEMORIAM Chairman of the Board Vice Chairman The McClatchy Company Founding International Chairman Patricia J. Matson Ligonier, PA *Dame Elizabeth Taylor Senior Vice President, Communications (ret.) ABC, Inc. Michele V. McNeill, Pharm.D. Sheldon W. Andelson, Esq. New York, NY Chairman Mrs. Albert D. Lasker McNeill Family Foundation Jonathan M. Mann, M.D., M.P.H. Vice Chairman Long Boat Key, FL Maxine Mesinger John C. Simons Pauline Phillips Managing Partner Edward L. Milstein Co-Chairman Natasha Richardson Corporate Fuel Partners LLC Allan Rosenfield, M.D. New York, NY Milstein Brothers Capital Partners New York, NY Peter Scott, Esq. Treasurer Tom Stoddard Wallace Sheft, C.P.A. Cindy D. Rachofsky Joel D. Weisman, D.O. Partner (ret.) Philanthropist Wurmbrand, Lerner & Sheft Dallas, TX Westbury, NY Vincent A. Roberti SPECIAL APPOINTMENT Secretary Chairman, Roberti+White Mervyn F. Silverman, M.D., M.P.H. Washington, D.C. Global Fundraising Chairman Crockett, CA Chairman and CEO Sharon Stone Palisades Media Corp. New York, NY

TRUSTEES Bill Roedy amfAR AMBASSADORS London, UK Arlen H. Andelson Cheyenne Jackson Raymond F. Schinazi, Ph.D., D.Sc. Janet Jackson Andelson Properties Frances Winship Walters Professor Los Angeles, CA Milla Jovovich Director, Laboratory of Biochemical Pharmacology Liza Minnelli Harry Belafonte Emory University Michelle Yeoh President Decatur, GA Belafonte Enterprises, Inc. Alan D. Schwartz New York, NY Executive Chairman BOARD COMMITTEES David Bohnett Guggenheim Partners LLC New York, NY Chairman Executive Committee David Bohnett Foundation Diana L. Taylor Kenneth Cole, Chair Beverly Hills, CA Managing Director Michael J. Klingensmith Zev Braun Wolfensohn & Co. LLC Mathilde Krim, Ph.D. President and CEO New York, NY Patricia J. Matson Vincent A. Roberti Braun Entertainment Group, Inc. Kevin Wendle Beverly Hills, CA Wallace Sheft, C.P.A. Entrepreneur Mervyn F. Silverman, M.D., M.P.H. Jonathan S. Canno Paris, France John C. Simons New York, NY Audit Committee Donald A. Capoccia Wallace Sheft, C.P.A., Chair Managing Principal ADJUNCT TRUSTEES R. Martin Chavez, Ph.D. BFC Partners John C. Simons Brooklyn, NY David E. Bloom, Ph.D. Clarence James Gamble Professor of Economics Board Development Committee R. Martin Chavez, Ph.D. and Demography Donald A. Capoccia, Co-Chair Managing Director Department of Global Health and Population Patricia J. Matson, Co-Chair Goldman, Sachs & Co. Harvard School of Public Health Arlen Andelson New York, NY Boston, MA David Bohnett Bill Roedy Jane B. Eisner Mario Stevenson, Ph.D. Mervyn F. Silverman, M.D., M.P.H. President Professor of Medicine The Eisner Foundation Chief, Division of Infectious Diseases Compensation and Organizational Development Bel Air, CA Leonard M. Miller School of Medicine Committee University of Miami John C. Simons, Chair Miami, FL Michael J. Klingensmith

13 12 Finance & Budget Committee David B. Clifford, M.D. Dianne M. Finkelstein, Ph.D. Michael J. Klingensmith, Chair Professor Director of Biostatistics Vincent A. Roberti Department of Neurology Cancer Center Biostatistics John C. Simons Washington University School of Medicine Massachusetts General Hospital and Harvard Medical School Fund Development Committee C. Budd Colby, Ph.D. Vincent A. Roberti, Chair Principal Gerald Herbert Friedland, M.D. Jonathan S. Canno Colby Biomedical Consultants Professor and Director, AIDS Program Edward L. Milstein Department of Internal Medicine Grant Colfax, M.D. Yale School of Medicine Investment Committee Director of HIV Prevention and Research Michael J. Klingensmith, Chair San Francisco Department of Public Health Howard E. Gendelman, M.D. R. Martin Chavez, Ph.D. Elizabeth Connick, M.D. David T. Purtilo Professor of Pathology and Edward L. Milstein Professor Microbiology Vincent A. Roberti Division of Infectious Diseases Department of Pathology and Microbiology Wallace Sheft, C.P.A. University of Colorado University of Nebraska Medical Center John C. Simons Deborah Jean Cotton, M.D., M.P.H. Nancy L. Haigwood, Ph.D. Professor of Medicine Director and Senior Scientist Department of Medicine Division of Pathobiology and Immunology Boston University School of Medicine Oregon National Primate Research Center SCIENTIFIC ADVISORY COMMITTEE Bryan Richard Cullen, Ph.D. Timothy Henrich, M.D. Professor Instructor in Medicine, Associate Physician Department of Genetics Department of Medicine, Infectious Diseases Duke University Medical Center Brigham and Women’s Hospital Mario Stevenson, Ph.D. (Chair) Professor of Medicine Susanna Cunningham-Rundles, Ph.D. Charles H. Hinkin, Ph.D. Chief, Division of Infectious Diseases Professor of Immunology Associate Professor Leonard M. Miller School of Medicine Department of Pediatrics Department of Psychiatry and Biobehavioral University of Miami Cornell University Medical College Science University of California School of Medicine Galit Alter, Ph.D. Richard Thomas D’Aquila, M.D. Associate Professor Director, Northwestern HIV Translational David Ho, M.D. Department of Medicine Research Center Scientific Director, Chief Executive Officer Harvard Medical School The Howard Taylor Rickets Professor of Aaron Diamond AIDS Research Center Medicine, Division of Infectious Diseases, Deborah Anderson, Ph.D. Department of Medicine Thomas J. Hope, Ph.D. Professor and Director Northwestern University Professor Division of Reproductive Biology Department of Cell and Molecular Biology Boston University School of Medicine Sherry Deren, Ph.D. Northwestern University, Feinberg School of Director Medicine Warren A. Andiman, M.D. Center for Drug Use and HIV Research Professor of Pediatrics, Epidemiology New York University College of Nursing Shiu-Lok Hu, Ph.D. and Public Health Professor Department of Pediatrics Roger Detels, M.D., M.S. School of Pharmacy Yale University School of Medicine Professor of Epidemiology University of Washington School of Public Health Michael Betts, Ph.D. University of California, Los Angeles Jonathan Karn, Ph.D. Associate Professor Director Department of Microbiology Carl W. Dieffenbach, Ph.D. Case Center for AIDS Research University of Pennsylvania School of Medicine Director Case Western Reserve University Division of AIDS (DAIDS) Jason Brenchley, Ph.D. National Institute of Allergy and Infectious Vineet KewalRamani, Ph.D. Senior Investigator Diseases Chief, Model Development Section Vaccine Research Center National Institutes of Health HIV Drug Resistance Program National Institute of Allergy and Infectious National Cancer Institute Diseases Daniel C. Douek, M.D., Ph.D. National Institutes of Health National Institutes of Health Chief, Human Immunology Section Vaccine Research Center Richard Kornbluth, M.D., Ph.D. Dennis R. Burton, Ph.D. National Institute of Allergy and Infectious President and Chief Scientific Officer Professor Diseases Multimeric Biotherapeutics, Inc. Department of Immunology National Institutes of Health The Scripps Research Institute Richard A. Koup, M.D. D. Peter Drotman, M.D., M.P.H. Chief, Immunology Laboratory Salvatore T. Butera, D.V.M., Ph.D. Editor in-Chief Vaccine Research Center Chief Science Officer Emerging Infectious Diseases National Institute of Allergy and Infectious Scripps CHAVI-ID Centers for Disease Control and Prevention Diseases The Scripps Research Institute National Institutes of Health Anke A. Ehrhardt, Ph.D. Edward Campbell, Ph.D. Director and Professor Nathaniel R. Landau, Ph.D. Assistant Professor Department of Psychiatry Professor School of Medicine Columbia University, NY State Psychiatric Institute Department of Microbiology Loyola University at Chicago New York University School of Medicine Homayoon Farzadegan, Ph.D. Alex Carballo-Dieguez, Ph.D. Professor Alan L. Landay, Ph.D. Research Scientist and Associate Professor of Department of Epidemiology Professor and Associate Chairman Clinical Psychology The Johns Hopkins University Department of Immunology and Microbiology HIV Center, NYS Psychiatric Institute Rush-Presbyterian-St. Luke’s Medical Center Columbia University

13 14 Michael Lederman, M.D. Nancy Padian, Ph.D., M.P.H. Leonidas Stamatatos, Ph.D. Scott R. Inkley Professor of Medicine, Department Executive Director Full Member and Director of Viral Vaccines of Medicine Women’s Global Health Imperative Program and Co-Director, Center for AIDS Research RTI International Seattle Biomedical Research Institute Case Western Reserve University Professor, Department of Obstetrics, Gynecology and Reproductive Sciences Ernest F. Terwilliger, Ph.D. Tun-Hou Lee, D.Sc. and Department of Epidemiology and Biostatistics Assistant Professor Professor of Virology University of California, San Francisco Beth Israel Deaconess Medical Center Department of Immunology and Infectious Diseases Savita Pahwa, M.D. Barbara Visscher, M.D., Dr.P.H. Harvard School of Public Health Director Professor of Epidemiology Microbiology and Immunology Department of Epidemiology Michael J. Leibowitz, M.D., Ph.D. Leonard M. Miller School of Medicine University of California, Los Angeles Professor University of Miami Department of Molecular Genetics and David Vlahov, Ph.D. Microbiology Tristram G. Parslow, M.D., Ph.D. Director University of Medicine and Dentistry of New William Patterson Timmie Professor and Chair Center for Urban Epidemiologic Studies Jersey-Robert Wood Johnson Medical School Department of Pathology and Laboratory Medicine New York Academy of Medicine Emory University School of Medicine Robert J. Levine, M.D. David J. Volsky, Ph.D. Professor of Medicine Matija Peterlin, M.D. Professor and Director Center for Interdisciplinary Research on AIDS Professor of Medicine, Microbiology and Department of Pathology and Medicine Yale University Immunology St. Luke’s-Roosevelt Hospital Center and Department of Medicine Columbia University Mathias Lichterfeld, M.D. University of California, San Francisco Assistant Professor of Medicine Steven S. Witkin, Ph.D. Department of Medicine Lynn Pulliam, Ph.D. Professor and Director Massachusetts General Hospital Professor Department of Obstetrics and Gynecology Department of Laboratory Medicine and Medicine Weill Medical College of Cornell University Judy Lieberman, M.D., Ph.D. University of California, San Francisco Senior Investigator Veterans Affairs Medical Center Peter R. Wolfe, M.D. Immune Disease Institute Associate Clinical Professor Professor of Pediatrics Lee Ratner, M.D., Ph.D. University of California, Los Angeles Harvard Medical School Professor Department of Medicine Richard T. Wyatt, Ph.D. H. Kim Lyerly, M.D. Washington University School of Medicine Professor of Immunology Professor in Surgery, Immunology, Pathology IAVI Center for Neutralizing Antibodies Duke Comprehensive Cancer Institute Andrew Rice, Ph.D. The Scripps Research Institute Duke University Medical Center Professor Department of Molecular Virology and Frank Maldarelli, M.D., Ph.D. Microbiology Investigator Baylor College of Medicine HIV DRP Host-Virus Interactions Branch PROGRAM ADVISORY National Cancer Institute Melissa Robbiani, Ph.D. National Institutes of Health Senior Scientist and Director of Biomedical HIV COUNCIL Research David M. Margolis, M.D. Center for Biomedical Research Professor of Microbiology, Medicine and Public Population Council Health Mervyn Silverman, M.D., M.P.H. (Chairman) School of Medicine Ruth M. Ruprecht, M.D., Ph.D. President University of North Carolina at Chapel Hill Professor of Medicine Mervyn F. Silverman Associates, Inc. Department of Cancer Immunology and AIDS Martin H. Markowitz, M.D. Dana-Farber Cancer Institute and Harvard Medical David Bloom, Ph.D. (Co-Chairman) Staff Investigator School Clarence James Gamble Professor of Economics Aaron Diamond AIDS Research Center and Demography Frederick A. Schmitt, Ph.D. Department of Global Health and Population Kenneth Hugh Mayer, M.D. Associate Professor Harvard School of Public Health Infectious Disease Attending & Director of HIV Departments of Neurology, Psychiatry and Prevention Research Psychology Mario Stevenson, Ph.D. (Co-Chairman) Beth Israel Deaconess Medical Center University of Kentucky Medical Center Professor of Medicine Professor of Medicine Chief, Division of Infectious Diseases Harvard Medical School Gerald Schochetman, Ph.D. University of Miami Medical Research Director, Co-Chair Director, AIDS Research and Retrovirus Discovery Leonard M. Miller School of Medicine The Fenway Institute/Fenway Health Abbott Laboratories Tim Brown, Ph.D. Joseph M. McCune, M.D., Ph.D. Robert Turner Schooley, M.D. Senior Fellow Professor of Medicine Academic Vice Chair The East-West Center Division of Experimental Medicine Professor and Head University of California, San Francisco Department of Medicine/Division of Infectious Daria J. Hazuda, Ph.D. Diseases Vice President of Scientific Affairs for Infectious Donna Mildvan, M.D. University of California, San Diego Disease Chief, Division of Infectious Diseases Merck & Company, Inc. Department of Medicine Gail Skowron, M.D. Beth Israel Medical Center Associate Professor of Medicine Department of Medicine, Division of Infectious Jay A. Nelson, Ph.D. Diseases Professor and Director Roger Williams Medical Center Division of Pathobiology and Immunology Oregon Health Sciences University

15 14 Kenneth H. Mayer, M.D. Infectious Disease Attending & Director of HIV Prevention Research Beth Israel Deaconess Medical Center Visiting Professor of Medicine Harvard Medical School Medical Research Director The Fenway Institute/Fenway Health

Jeffrey L. Sturchio, Ph.D. Senior Partner Rabin Martin, New York Visiting Scholar The Institute for Applied Economics, Global Health and the Study of Business Enterprise Johns Hopkins University Member, The Council on Foreign Relations

Phill Wilson Chief Executive Officer and President The Black AIDS Institute

MANAGEMENT GROUP

Kevin Robert Frost Chief Executive Officer Anthony Ancona Vice President and Director, Human Resources Susan J. Blumenthal, M.D., M.P.A. Senior Policy and Medical Advisor Gregory Boroff, C.A.E., C.F.R.E. Vice President and Director, Development Chris Collins, M.P.P. Vice President and Director, Public Policy Bradley Jensen Chief Financial Officer Rowena Johnston, Ph.D. Vice President and Director, Research Jeffrey Laurence, M.D. Senior Scientific Consultant for Programs John F. Logan, Ph.D., J.D. Vice President and General Counsel AnnMari Shannahan Vice President, Public Information Annette Sohn, M.D. Vice President and Director, TREAT Asia

15 17 amfAR, The Foundation for AIDS Research

NEW YORK 120 Wall Street, 13th Floor New York, NY 10005-3908 (212) 806-1600 (tel) (212) 806-1601 (fax)

WASHINGTON, D.C. 1150 17th Street, NW Suite 406 Washington, DC 20036-4622 (202) 331-8600 (tel) (202) 331-8606 (fax)

BANGKOK, THAILAND TREAT Asia Exchange Tower 388 Sukhumvit Road, Suite 2104 Klongtoey, Bangkok 10110 Thailand +66 (0)2 663 7561 (tel) +66 (0)2 663 7562 (fax) www.amfar.org

amfAR meets the BBB Wise Giving Alliance’s Standards for Charity Accountability.